シタグリプチン含有錠剤 - Japan Generic Co., Ltd.

Title:

シタグリプチン含有錠剤

Document Type and Number:

Japanese Patent JP7423264

Kind Code:

B2

Abstract:

To provide a sitagliptin phosphate tablet having improved chemical stability.SOLUTION: A tablet contains sitagliptin, a pharmacologically acceptable salt thereof, or a hydrate thereof, and one or more lubricants selected from the group consisting of stearic acid, sodium stearyl fumarate, sucrose fatty acid ester, hardened oil, and talc.SELECTED DRAWING: None

More Like This:

JP4593880	Substituted 4H-chromen and analogs as caspase activators and apoptosis inducers, and how to use them
JP2023553809	Pyridylpyridone derivatives as VSP34 inhibitors for use in the treatment of viral infections
WO/2016/086026	CRYSTALLINE FORMS OF A THERAPEUTIC COMPOUND AND USES THEREOF

Inventors:

Yuki Sugawara
The wealthy Shinnosuke

Application Number:

JP2019201049A

Publication Date:

January 29, 2024

Filing Date:

October 17, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Japan Generic Co., Ltd.

International Classes:

A61K31/4985; A61K9/20; A61K47/04; A61K47/12; A61K47/14; A61K47/26; A61K47/38; A61K47/44; A61P3/10

Domestic Patent References:

JP2019172672A
JP2013538814A
JP2020121950A
JP4573542B2

Foreign References:

US20150374688
WO2015114152A1

Attorney, Agent or Firm:

Sykes Patent Attorney Corporation

Previous Patent: Image forming device

Next Patent: Parts holding status acquisition device